InvestorsHub Logo
Followers 4
Posts 59
Boards Moderated 0
Alias Born 07/15/2019

Re: snow post# 20763

Friday, 11/22/2019 10:32:56 AM

Friday, November 22, 2019 10:32:56 AM

Post# of 54907
Snow, part of it is price. Predictive has a tier price structure for the cell based products like other companies. If I place an order for 10k worth of product I pay more per cc versus buying 15k or greater than 20k. Some companies don’t do this. If I want to use 5 ccs of product for a patient my price for an exosome product could be 2250. Same amount of product from PB can cost me double that. Many of us heard about the claim of changing of the characterization report well before the HB piece which turned a lot of docs off to the product, not all but many in my circle. Some providers are just using bone marrow MSC derived exosomes which Predictive does not offer at this point. The point is there are several reasons in this ever changing area of regenerative medicine.